Advanced
  Home Compare Reports

Comparison with Similar Reports

Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker L...

Publisher:        MarketsandMarkets

# of Pages:        376

Rating: 

1 User License $4,950

Publication Date:  December, 2021

Price:       $4,950 / User License




1 INTRODUCTION 48
1.1 OBJECTIVES OF THE STUDY 48
1.2 MARKET DEFINITION 48
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE LATERAL FLOW ASSAYS MARKET 48
1.3 MARKET SCOPE 49
1.3.1 MARKETS COVERED 49
FIGURE 1 LATERAL FLOW ASSAYS MARKET SEGMENTATION 49
FIGURE 2 LATERAL FLOW ASSAYS MARKET, BY REGION 50
1.3.2 YEARS CONSIDERED FOR THE STUDY 50
1.4 CURRENCY 51
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 51
1.5 STAKEHOLDERS 51
1.6 SUMMARY OF CHANGES 51
2 RESEARCH METHODOLOGY 53
2.1 RESEARCH APPROACH 53
FIGURE 3 RESEARCH DESIGN 53
2.1.1 SECONDARY DATA 53
2.1.1.1 Key data from secondary sources 54
2.1.2 PRIMARY DATA 55
2.1.2.1 Primary sources 55
2.1.2.2 Key data from primary sources 56
2.1.2.3 Breakdown of primaries 56
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 56
2.2 MARKET SIZE ESTIMATION 57
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2020) 58
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2020) 58
FIGURE 7 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON THE MALARIA LATERAL FLOW TESTING MARKET SIZE (2020) 59
FIGURE 8 APPROACH 4: TOP-DOWN APPROACH 59
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE LATERAL FLOW ASSAYS MARKET (2020) 61
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 62
FIGURE 10 DATA TRIANGULATION METHODOLOGY 62
2.4 KEY INDUSTRY INSIGHTS 63
2.5 LIMITATIONS 63
2.5.1 METHODOLOGY-RELATED LIMITATIONS 63
2.6 RISK ASSESSMENT 64
2.7 ASSUMPTIONS FOR THE STUDY 64
3 EXECUTIVE SUMMARY 65
FIGURE 11 LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 65
FIGURE 12 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,
2021 VS. 2026 (USD MILLION) 66
FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 66
FIGURE 14 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2021 VS. 2026 (USD MILLION) 67
FIGURE 15 LATERAL FLOW ASSAYS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 68
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAYS MARKET 69
4 PREMIUM INSIGHTS 70
4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW 70
FIGURE 17 RISING COVID-19 PATIENT POPULATION AND GROWTH IN THE PREVALENCE OF INFECTIOUS DISEASES ARE DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET 70
4.2 REGIONAL MIX: LATERAL FLOW ASSAYS MARKET 71
FIGURE 18 APAC TO REGISTER THE HIGHEST CAGR OF 5.8% DURING THE FORECAST PERIOD 71
4.3 ASIA PACIFIC LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY 72
FIGURE 19 CLINICAL TESTING SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN
ASIA PACIFIC 72
4.4 LATERAL FLOW ASSAYS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 73
FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATES DURING THE FORECAST PERIOD 73
4.5 LATERAL FLOW ASSAYS MARKET: DEVELOPING VS DEVELOPED COUNTRIES 73
FIGURE 21 DEVELOPING COUNTRIES TO OFFER HIGHER GROWTH 73
5 MARKET OVERVIEW 74
5.1 INTRODUCTION 74
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 74
5.2.1 DRIVERS 75
5.2.1.1 High prevalence of infectious diseases across the globe 75
FIGURE 22 PREVALENCE OF INFECTIOUS DISEASES WORLDWIDE 75
TABLE 2 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2020) 76
5.2.1.2 Rapidly increasing geriatric population 76
FIGURE 23 GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION) 77
FIGURE 24 GERIATRIC POPULATION, BY COUNTRY, 2020 VS. 2060 (MILLION) 77
5.2.1.3 Growing usage of home-based lateral flow assay devices 78
5.2.1.4 Growing demand for point-of-care testing 78
5.2.1.5 Need for rapid diagnostic testing for COVID-19 79
FIGURE 25 NUMBER OF CONFIRMED CASES OF COVID-19, BY WHO REGION (MILLION) 79
5.2.2 RESTRAINTS 80
5.2.2.1 Inconsistent results of lateral flow assay tests 80
5.2.3 OPPORTUNITIES 80
5.2.3.1 Evolving applications of lateral flow assays 80
TABLE 3 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS 81
5.2.3.2 Rising demand for lateral flow assays in the food & beverage industry 81
5.2.4 CHALLENGES 82
5.2.4.1 Limited reimbursements for lateral flow assay products 82
5.2.4.2 Difficulties in procuring quality raw materials for the development of lateral flow assay tests 82
5.3 COVID-19 ECONOMIC ASSESSMENT 83
5.4 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 83
FIGURE 26 CRITERIA IMPACTING THE GLOBAL ECONOMY 83
5.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAYS MARKET 84
5.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN LATERAL FLOW ASSAYS MARKET 85
FIGURE 27 YC–YCC SHIFT IN LATERAL FLOW ASSAYS MARKET 85
5.7 AVERAGE SELLING PRICE TREND 85
TABLE 4 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 86
TABLE 5 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS) 86
5.8 ECOSYSTEM MARKET MAP 87
FIGURE 28 ECOSYSTEM: LATERAL FLOW ASSAYS MARKET (2020) 87
5.9 PATENT ANALYSIS 88
5.9.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAY 88
FIGURE 29 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAYS MARKET, 2016-2021 89
5.9.2 TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAYS PATENTS 89
FIGURE 30 TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAYS PATENTS, 2016–2021 89
5.9.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN LATERAL FLOW ASSAYS MARKET 90
FIGURE 31 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS PATENTS, 2016–2021 90
5.10 VALUE CHAIN ANALYSIS 90
FIGURE 32 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2020) 91
5.11 TECHNOLOGY ANALYSIS 91
5.11.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 91
5.11.2 ADJACENT TECHNOLOGY: ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS) 91
5.12 CASE STUDY ANALYSIS 92
5.13 REGULATORY LANDSCAPE 93
TABLE 6 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 93
5.13.1 NORTH AMERICA 93
5.13.2 EUROPE 94
5.13.3 ASIA 94
5.13.3.1 India 94
5.13.3.2 China 95
5.13.3.3 Japan 95
5.14 PORTER’S FIVE FORCES ANALYSIS 95
TABLE 7 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 95
5.14.1 THREAT FROM NEW ENTRANTS 96
5.14.2 THREAT FROM SUBSTITUTES 97
5.14.3 BARGAINING POWER OF SUPPLIERS 97
5.14.4 BARGAINING POWER OF BUYERS 97
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 97
5.15 ADJACENT MARKET ANALYSIS 98
6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT 99
6.1 INTRODUCTION 100
TABLE 8 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 100
6.2 KITS & REAGENTS 100
6.2.1 INCREASING DEMAND FOR POC TESTING IS DRIVING THE DEMAND FOR KITS & REAGENTS IN THE LATERAL FLOW ASSAYS MARKET 100
TABLE 9 LATERAL FLOW KITS & REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 101
6.3 LATERAL FLOW ASSAYS READERS MARKET 102
TABLE 10 EXAMPLES OF LATERAL FLOW READERS AVAILABLE IN THE MARKET 102
TABLE 11 LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS 103
TABLE 12 LATERAL FLOW READERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 104
TABLE 13 LATERAL FLOW READERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 104
TABLE 14 LATERAL FLOW READERS MARKET, BY END USER,
2019–2026 (USD MILLION) 104
TABLE 15 LATERAL FLOW READERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
6.3.1 DIGITAL/HANDHELD READERS 105
6.3.1.1 Technological advancements and high accuracy are the major factors driving the growth of the digital/handheld readers market 105
TABLE 16 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 106
TABLE 17 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY REGION,
2019–2026 (THOUSAND UNITS) 107
6.3.2 BENCHTOP READERS 107
6.3.2.1 Lower diagnosis cost per patient is driving the benchtop readers market 107
TABLE 18 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
TABLE 19 BENCHTOP LATERAL FLOW READERS VOLUME, REGION,
2019–2026 (THOUSAND UNITS) 108
6.4 INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW ASSAY READERS 109
6.5 LATERAL FLOW ASSAYS READERS MARKETS FOR CLINICAL DIAGNOSTICS APPLICATIONS, BY TYPE 109
6.5.1 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW ASSAYS READERS FOR CLINICAL DIAGNOSTICS APPLICATION 109
TABLE 20 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW ASSAYS READERS FOR CLINICAL DIAGNOSTICS APPLICATION 109
FIGURE 33 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW ASSAYS READERS FOR CLINICAL DIAGNOSTICS (2020) 111
7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION 112
7.1 INTRODUCTION 113
TABLE 21 LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 113
7.2 CLINICAL TESTING 113
TABLE 22 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE,
2019–2026 (USD MILLION) 114
TABLE 23 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 114
7.2.1 INFECTIOUS DISEASE TESTING 115
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY DISEASE TYPE, 2019–2026 (USD MILLION) 115
TABLE 25 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY COUNTRY, 2019–2026 (USD MILLION) 116
7.2.1.1 Mosquito-borne diseases 116
7.2.1.1.1 Increasing incidence of dengue is driving the growth of
the lateral flow assays market for mosquito-borne diseases 116
TABLE 26 MAJOR PRODUCTS: DENGUE TESTING 117
TABLE 27 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION) 118
7.2.1.2 COVID-19 118
7.2.1.2.1 The ongoing COVID-19 pandemic to drive the demand for rapid lateral flow tests 118
TABLE 28 COVID-19 (ANTIGEN AND ANTIBODY) LATERAL FLOW ASSAY TESTS 119
TABLE 29 LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY,
2019–2026 (USD MILLION) 120
7.2.1.3 Influenza 120
7.2.1.3.1 Growing prevalence of influenza globally is expected to boost market growth 120
TABLE 30 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY,
2019–2026 (USD MILLION) 121
7.2.1.4 Sexually transmitted infections 121
TABLE 31 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 32 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2019–2026 (USD MILLION) 123
7.2.1.4.1 HIV 123
7.2.1.4.1.1 Growing awareness about HIV POC testing is one of
the major factors driving market growth 123
TABLE 33 LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY,
2019–2026 (USD MILLION) 124
7.2.1.4.2 HPV 124
7.2.1.4.2.1 Rising adoption of HPV testing to drive the market during the forecast period 124
TABLE 34 LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY,
2019–2026 (USD MILLION) 125
7.2.1.4.3 Chlamydia 126
7.2.1.4.3.1 Growing incidence of chlamydia and rising awareness among patients drive market growth 126
TABLE 35 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2019–2026 126
7.2.1.4.4 Gonorrhea 127
7.2.1.4.4.1 Rising incidence of gonorrhea globally and increased funding for R&D to drive the lateral flow assays market during the forecast period 127
TABLE 36 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY,
2019–2026 (USD MILLION) 128
7.2.1.4.5 Syphilis 128
7.2.1.4.5.1 Growing adoption of novel technologies supporting the growth of the lateral flow assays market for syphilis testing 128
TABLE 37 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY,
2019–2026 (USD MILLION) 129
7.2.1.4.6 Other sexually transmitted infections 130
TABLE 38 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2019–2026 (USD MILLION) 130
7.2.1.5 Hepatitis 130
7.2.1.5.1 Nucleic acid hybridization-based lateral flow assays hold great potential in the hepatitis testing market 130
TABLE 39 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY,
2019–2026 (USD MILLION) 131
7.2.1.6 Tuberculosis 132
7.2.1.6.1 Rising prevalence and growing focus on early diagnosis and treatment drive the market 132
TABLE 40 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY,
2019–2026 (USD MILLION) 132
7.2.1.7 Other infectious diseases 133
TABLE 41 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION) 133
7.2.2 CARDIAC MARKER TESTING 134
TABLE 42 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 43 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY COUNTRY, 2019–2026 (USD MILLION) 135
7.2.2.1 Troponin I & T 135
7.2.2.1.1 Introduction of high-sensitivity troponin assays to drive this market during the forecast period 135
TABLE 44 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 136
7.2.2.2 CK-MB 136
7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive this market 136
TABLE 45 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY,
2019–2026 (USD MILLION) 137
7.2.2.3 BNP and NT-proBNP 137
7.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to drive growth in this market 137
TABLE 46 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING,
BY COUNTRY, 2019–2026 (USD MILLION) 138
7.2.2.4 Myoglobin 138
7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict the growth of the routine myoglobin testing market 138
TABLE 47 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 139
7.2.2.5 D-Dimer 139
7.2.2.5.1 Rising incidence of cardiovascular diseases to drive
the market for D-dimer tests 139
TABLE 48 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 140
7.2.2.6 Other cardiac markers 140
TABLE 49 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS,
BY COUNTRY, 2019–2026 (USD MILLION) 141
7.2.3 PREGNANCY & FERTILITY TESTING 141
TABLE 50 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,
BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 51 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,
BY COUNTRY, 2019–2026 (USD MILLION) 142
7.2.3.1 Pregnancy testing 143
7.2.3.1.1 Pregnancy testing is among the most common application areas for lateral flow assays, registering slower growth during the forecast period 143
TABLE 52 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 143
7.2.3.2 Fertility testing 144
7.2.3.2.1 Rising infertility rates across the globe driving the demand for POC fertility testing kits 144
TABLE 53 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 144
7.2.4 CHOLESTEROL/LIPID TESTING 145
7.2.4.1 Growing prevalence of obesity and CVD is the key factor driving market growth 145
TABLE 54 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING,
BY COUNTRY, 2019–2026 (USD MILLION) 145
7.2.5 DRUGS-OF-ABUSE TESTING 146
7.2.5.1 Technological advancements and growing focus on workplace drug testing are driving market growth 146
TABLE 55 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING,
BY COUNTRY, 2019–2026 (USD MILLION) 147
7.2.6 OTHER CLINICAL TESTS 147
TABLE 56 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2019–2026 (USD MILLION) 148
7.3 VETERINARY DIAGNOSTICS 148
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 148
TABLE 57 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS,
BY COUNTRY, 2019–2026 (USD MILLION) 149
7.4 FOOD SAFETY & ENVIRONMENT TESTING 149
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 149
TABLE 58 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 150
7.5 DRUG DEVELOPMENT & QUALITY TESTING 151
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE IS DRIVING THE GROWTH OF THIS MARKET 151
TABLE 59 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 151
8 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE 152
8.1 INTRODUCTION 153
TABLE 60 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 153
8.2 SANDWICH ASSAYS 153
8.2.1 WIDE APPLICATIONS OF SANDWICH ASSAYS IN CLINICAL TESTING CONTRIBUTE TO THE LARGEST SHARE OF THIS SEGMENT 153
TABLE 61 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 154
8.3 COMPETITIVE ASSAYS 155
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER GROWTH 155
TABLE 62 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 155
 
8.4 MULTIPLEX DETECTION ASSAYS 156
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE THE GROWTH OF THIS MARKET 156
TABLE 63 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 156
9 LATERAL FLOW ASSAYS FOR CLINICAL TESTING MARKET, BY SAMPLE TYPE 157
9.1 INTRODUCTION 158
TABLE 64 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 158
9.2 BLOOD SAMPLES 158
9.2.1 INCREASING USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE THE GROWTH OF THIS SEGMENT 158
TABLE 65 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY,
2019–2026 (USD MILLION) 159
9.3 URINE SAMPLES 159
9.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY TESTING AND DRUGS-OF-ABUSE TESTING TO DRIVE THE GROWTH OF THIS MARKET 159
TABLE 66 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY,
2019–2026 (USD MILLION) 160
9.4 SALIVA SAMPLES 160
9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES ARE THE KEY FACTORS DRIVING MARKET GROWTH 160
TABLE 67 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY,
2019–2026 (USD MILLION) 161
9.5 OTHER SAMPLES 161
TABLE 68 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES,
BY COUNTRY, 2019–2026 (USD MILLION) 162
10 LATERAL FLOW ASSAYS MARKET, BY END USER 163
10.1 INTRODUCTION 164
TABLE 69 LATERAL FLOW ASSAYS MARKET, BY END USER, 2019–2026 (USD MILLION) 164
10.2 HOSPITALS & CLINICS 164
10.2.1 INCREASING USE OF POC TESTS DRIVING THE ADOPTION OF LATERAL FLOW ASSAYS AMONG HOSPITALS & CLINICS 164
TABLE 70 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 165
10.3 DIAGNOSTIC LABORATORIES 165
10.3.1 LABORATORY TESTING IS LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING—A KEY FACTOR DRIVING MARKET GROWTH 165
TABLE 71 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES,
BY COUNTRY, 2019–2026 (USD MILLION) 166
10.4 HOME CARE SETTINGS 166
10.4.1 GROWING ACCEPTANCE OF REMOTE MONITORING DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET FOR HOME CARE 166
TABLE 72 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION) 167
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 167
10.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE THE USE OF LATERAL FLOW ASSAYS AMONG PHARMACEUTICAL & BIOTECH COMPANIES 167
TABLE 73 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 168
10.6 OTHER END USERS 168
TABLE 74 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 169
11 LATERAL FLOW ASSAYS MARKET, BY REGION 170
11.1 INTRODUCTION 171
FIGURE 34 US TO DOMINATE THE LATERAL FLOW ASSAYS MARKET DURING THE FORECAST PERIOD 171
TABLE 75 LATERAL FLOW ASSAYS MARKET, BY REGION, 2019–2026 (USD MILLION) 172
11.2 NORTH AMERICA 173
TABLE 76 NORTH AMERICA: MACROECONOMIC INDICATORS 173
FIGURE 35 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT 174
TABLE 77 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 175
TABLE 78 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 175
TABLE 79 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 80 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 176
TABLE 81 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 82 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 177
TABLE 83 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 177
TABLE 84 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 85 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 86 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,
BY TECHNIQUE, 2019–2026 (USD MILLION) 179
TABLE 87 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 179
TABLE 88 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 180
11.2.1 US 180
11.2.1.1 The US accounts for the largest share of the lateral flow assays market in North America 180
TABLE 89 US: MACROECONOMIC INDICATORS 181
TABLE 90 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 181
TABLE 91 US: LATERAL FLOW READERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 92 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 182
TABLE 93 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 94 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY DISEASE TYPE, 2019–2026 (USD MILLION) 183
TABLE 95 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 96 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 97 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 98 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 184
TABLE 99 US: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 185
TABLE 100 US: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 USD MILLION) 185
11.2.2 CANADA 185
11.2.2.1 Availability of research funding and implementation of favorable government initiatives are driving the market in Canada 185
TABLE 101 CANADA: MACROECONOMIC INDICATORS 186
TABLE 102 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 186
TABLE 103 CANADA: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 104 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 187
TABLE 105 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 106 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 188
TABLE 107 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 108 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 109 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 110 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 190
TABLE 111 CANADA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 190
TABLE 112 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 191
11.3 EUROPE 191
FIGURE 36 EUROPE: LATERAL FLOW ASSAYS MARKET SNAPSHOT 192
TABLE 113 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 193
TABLE 114 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 193
TABLE 115 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 116 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 194
TABLE 117 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 118 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 195
TABLE 119 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 120 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 121 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 122 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 196
TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 197
TABLE 124 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 197
11.3.1 GERMANY 197
11.3.1.1 Growing number of POC diagnostics centers to drive the demand for lateral flow assays in Germany 197
TABLE 125 GERMANY: MACROECONOMIC INDICATORS 198
TABLE 126 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 198
TABLE 127 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 128 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 199
TABLE 129 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 130 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 200
TABLE 131 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 132 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 201
TABLE 133 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 201
TABLE 134 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,
BY TECHNIQUE, 2019–2026 (USD MILLION) 201
TABLE 135 GERMANY: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 202
TABLE 136 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 202
11.3.2 FRANCE 202
11.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 202
TABLE 137 FRANCE: MACROECONOMIC INDICATORS 203
TABLE 138 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 203
TABLE 139 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 203
TABLE 140 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 204
TABLE 141 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 142 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 205
TABLE 143 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 144 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 145 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 146 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 206
TABLE 147 FRANCE: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 207
TABLE 148 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 207
11.3.3 UK 207
11.3.3.1 Increasing incidence of chronic diseases and rising prevalence of obesity propelling the market growth in the UK 207
TABLE 149 UK: MACROECONOMIC INDICATORS 208
TABLE 150 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 208
TABLE 151 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 209
TABLE 152 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 209
TABLE 153 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 154 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY DISEASE TYPE, 2019–2026 (USD MILLION) 210
TABLE 155 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 156 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 157 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 212
TABLE 158 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 212
TABLE 159 UK: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 212
TABLE 160 UK: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 213
11.3.4 ITALY 213
11.3.4.1 Growing initiatives towards the decentralization of medical services in Italy are contributing to market growth 213
TABLE 161 ITALY: MACROECONOMIC INDICATORS 213
TABLE 162 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 214
TABLE 163 ITALY: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 214
TABLE 164 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 215
TABLE 165 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 166 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 216
TABLE 167 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 168 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 169 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 170 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 217
TABLE 171 ITALY: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 218
TABLE 172 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 218
11.3.5 SPAIN 218
11.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 218
TABLE 173 SPAIN: MACROECONOMIC INDICATORS 219
TABLE 174 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 219
TABLE 175 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 219
TABLE 176 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 220
TABLE 177 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 178 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 221
TABLE 179 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 221
TABLE 180 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 222
TABLE 181 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 222
TABLE 182 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 222
TABLE 183 SPAIN: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 223
TABLE 184 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 223
11.3.6 REST OF EUROPE 223
TABLE 185 ROE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 224
TABLE 186 ROE: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 187 ROE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 224
TABLE 188 ROE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 189 ROE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY DISEASE TYPE, 2019–2026 (USD MILLION) 225
TABLE 190 ROE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 191 ROE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 192 ROE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 227
TABLE 193 ROE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 227
TABLE 194 ROE: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 227
TABLE 195 ROE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 228

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127